Literature DB >> 80437

Sequential precipitation of mouse thymocyte extracts with anti-Lyt-2 and anti-Lyt-3 sera. I. Lyt-2.1 and Lyt-3.1 antigenic determinants reside on separable molecular species.

P J Durda, P D Gottlieb.   

Abstract

Anti-Lyt-2.1 and anti-Lyt-3.1 sera were employed for sequential precipitation of NP-40 extracts of 125I-labeled C57BL/6-Lyt-2a, Lyt-3a thymocytes (Lyt-2.1, Lyt-3.1) to determine whether these alloantigenic determinants are present on the same or different molecular species. Treatment of extracts with anti-Lyt-3.1 serum and SaCI completely precipitated both Lyt-3.1 and Lyt-2.1-specific components, whereas treatment with anti-Lyt-2.1 serum reduced by approximately 37% the quantity of labeled species subsequently precipitable by anti-Lyt-3.1 serum. When 125I-labeled thymocytes were subjected to mild trypsinization before NP-40 extraction, the quantity of radioactive components precipitated by anti-Lyt-2.1 serum was essentially unchanged, but that of anti-Lyt-3.1-precipitable components was greatly reduced. Moreover, sequential precipitation of extracts of trypsinized thymocytes with anti-Lyt-2.1 and anti-Lyt-3.1 sera demonstrated that these molecular species were precipitated independently. Thus 1) Lyt-2.1 and Lyt-3.1 antigenic determinants appear to reside on different molecular species; 2) some Lyt-2.1- and Lyt-3.1-positive molecules appear to be complexed with each other in the NP-40 extract; and 3) this association of Lyt-2.1- and Lyt-3.1-positive species was dependent upon components that were labile to trypsinization of intact thymocytes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 80437

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Inducible functions in hybrids of a Lyt-2+ BW5147 transfectant and the 2C CTL line.

Authors:  J J Gu; P D Gottlieb
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Mutants of cultured mouse cells deficient in Ly-2 antigen.

Authors:  D Iannelli; R Palomba; R Capparelli; F Scala; A Iannelli; L Ferrara; T Uchida
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

3.  Differential susceptibility of mouse Lyt-2 and Lyt-3 genes to negative regulation.

Authors:  I Hwang; J J Gu; P D Gottlieb
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

4.  Construction and properties of new Lyt-congenic strains and anti-Lyt-2.2 and anti-Lyt-3.1 monoclonal antibodies.

Authors:  P D Gottlieb; A Marshak-Rothstein; K Auditore-Hargreaves; D B Berkoben; D A August; R M Rosche; J D Benedetto
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

5.  Structure and expression of the Lyt-3a gene of C.AKR mice.

Authors:  H J Youn; J V Harriss; P D Gottlieb
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Mouse Lyt-2 antigen: evidence for two heterodimers with a common subunit.

Authors:  G Jay; M A Palladino; G Khoury; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

7.  Cell surface polypeptides of murine T-cell clones expressing cytolytic or amplifier activity.

Authors:  M Sarmiento; A L Glasebrook; F W Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

8.  Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes: analysis by antibody blocking and selective trypsinization.

Authors:  H R MacDonald; A L Glasebrook; J C Cerottini
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

9.  Lyt-2 glycoprotein is synthesized as a single molecular species.

Authors:  E Rothenberg; D Triglia
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

10.  Lyt-2 and lyt-3 antigens are on two different polypeptide subunits linked by disulfide bonds. Relationship of subunits to T cell cytolytic activity.

Authors:  J A Ledbetter; W E Seaman; T T Tsu; L A Herzenberg
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.